TCL Archive Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence December 26, 2008
TCL Archive Genentech: ODAC Lacks Expertise, Impartiality; FDA: Company’s Proposal Unscientific August 12, 2011